
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.
| Revenue (TTM) | $1.58B |
| Gross Profit (TTM) | $781.73M |
| EBITDA | $338.94M |
| Operating Margin | 14.50% |
| Return on Equity | 9.19% |
| Return on Assets | 4.92% |
| Revenue/Share (TTM) | $26.56 |
| Book Value | $28.13 |
| Price-to-Book | 3.23 |
| Price-to-Sales (TTM) | 3.39 |
| EV/Revenue | 3.668 |
| EV/EBITDA | 15.99 |
| Quarterly Earnings Growth (YoY) | 20.40% |
| Quarterly Revenue Growth (YoY) | 9.50% |
| Shares Outstanding | $59.71M |
| Float | $58.29M |
| % Insiders | 2.44% |
| % Institutions | 108.22% |
Volatility is currently contracting

Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript

Investors interested in Medical - Dental Supplies stocks are likely familiar with The Cooper Companies (COO) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?

SOUTH JORDAN, Utah, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management will participate in the upcoming investor conferences:

Merit Medical's Q2 adjusted EPS jumps 18% as revenues rise 9.5%, margins expand and 2026 guidance increases after broad product growth.

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday.

Merit Medical Systems, Inc. (MMSI) Q2 2026 Earnings Call Transcript

Financial Highlights† Reported revenue of $418.8 million, up 10% Constant currency revenue* and constant currency revenue, organic* up 9% and up 9%, respectively GAAP operating margin of 14.4%, compared to 12.3% in prior year period Non-GAAP operating margin* of 22.6%, compared to 21.2% in prior year period GAAP EPS $0.65, up 20% Non-GAAP EPS* $1.19, up 18% Cash flow from operations of $110.0 million year-to-date, down 11% Free cash flow* generation of $76.6 million year-to-date, down 14% † Comparisons above are calculated for the current quarter compared with the second quarter of 2025, unless otherwise specified. Amounts stated in this release are rounded, while percentages are calculated from the underlying amounts.

Medical product makers face Q2 margin pressure from tariffs and inflation even as demand stays strong. See which earnings reports could surprise.

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or West Pharmaceutical Services (WST). But which of these two stocks is more attractive to value investors?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MMSI and any ticker you trade — then tracks every position and per-strategy win rate.